These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1591381)

  • 1. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma.
    Bataille R; Chappard D; Klein B
    Int J Clin Lab Res; 1992; 21(4):283-7. PubMed ID: 1591381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of bone lesions in multiple myeloma and lymphoma.
    Roodman GD
    Cancer; 1997 Oct; 80(8 Suppl):1557-63. PubMed ID: 9362422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the pathogenesis of osteolysis in multiple myeloma patients.
    Giuliani N; Colla S; Rizzoli V
    Acta Biomed; 2004 Dec; 75(3):143-52. PubMed ID: 15796087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone hyperresorption in multiple myeloma].
    Beaudreuil J; Orcel P
    Presse Med; 2000 Mar; 29(9):492-7. PubMed ID: 10745943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multiple myeloma bone eco-system and its relation to oncogenesis.
    Bataille R
    Morphologie; 2015 Jun; 99(325):31-7. PubMed ID: 26005000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of bone lesions in multiple myeloma.
    Bataille R; Chappard D; Klein B
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):285-95. PubMed ID: 1582975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of clodronate in multiple myeloma.
    Delmas PD
    Bone; 1991; 12 Suppl 1():S31-4. PubMed ID: 1835398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of bone destruction in multiple myeloma.
    Terpos E; Christoulas D; Gavriatopoulou M; Dimopoulos MA
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28940410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of osteoclast function.
    Suda T; Nakamura I; Jimi E; Takahashi N
    J Bone Miner Res; 1997 Jun; 12(6):869-79. PubMed ID: 9169344
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of osteolytic bone destruction.
    Mundy GR
    Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of myeloma bone disease.
    Roodman GD
    Leukemia; 2009 Mar; 23(3):435-41. PubMed ID: 19039321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of multiple myeloma bone disease.
    Lentzsch S; Ehrlich LA; Roodman GD
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1035-49, viii. PubMed ID: 17996587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokine-mediated bone resorption].
    Nakamura M; Uehara S; Nakamura H; Udagawa N
    Clin Calcium; 2014 Jun; 24(6):837-44. PubMed ID: 24870834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
    Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
    Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone hyperresorption in neoplastic diseases. Foreword].
    Vinceneux P
    Presse Med; 2000 Mar; 29(9):485-6. PubMed ID: 10745941
    [No Abstract]   [Full Text] [Related]  

  • 16. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
    Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
    J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glucocorticoids on the biologic activities of myeloma cells: inhibition of interleukin-1 beta osteoclast activating factor-induced bone resorption.
    Ishikawa H; Tanaka H; Iwato K; Tanabe O; Asaoku H; Nobuyoshi M; Yamamoto I; Kawano M; Kuramoto A
    Blood; 1990 Feb; 75(3):715-20. PubMed ID: 2297574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.
    Bataille R; Chappard D; Marcelli C; Dessauw P; Baldet P; Sany J; Alexandre C
    J Clin Invest; 1991 Jul; 88(1):62-6. PubMed ID: 2056131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the secretion of an osteoclast stimulating factor in myeloma.
    Mundy GR; Raisz LG; Cooper RA; Schechter GP; Salmon SE
    N Engl J Med; 1974 Nov; 291(20):1041-6. PubMed ID: 4413338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.